Savient (SVNT) Shares Rally 20+% Amid FDA Approval of Krystexxa
Tweet Send to a Friend
Shares of Savient Pharma (Nasdaq: SVNT) are up more than 24% on very heavy volume in the pre-market session following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


